Skip to main content

Posts

Showing posts with the label boston

Best biotech investment newsletter

It invites contributions from industry professionals from manufacturers to regulators. Advanced Search Submit entry for keyword results. AUPH is a small biotech which is developing a drug,vocolsporin for lupus nephritis. By Michael Brush Columnist. Immunotherapies work well against cancers, but they have their shortcomings.